Bivalent cholera and typhoid vaccine

Drugs

Volumn 58, Issue 1, 1999, Pages 91-96

  Foster, Rachel H ^a   Noble, Stuart ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; LIVE VACCINE; MEFLOQUINE; ORAL POLIOMYELITIS VACCINE; PROGUANIL; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ABDOMINAL PAIN; ANTIBODY TITER; ARTICLE; CHOLERA; CLINICAL TRIAL; DIARRHEA; DRUG TOLERABILITY; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; ORAL DRUG ADMINISTRATION; SALMONELLA TYPHI; SEROCONVERSION; TYPHOID FEVER; VACCINE PRODUCTION; VIBRIO CHOLERAE;

BACTERIAL VACCINES; CHOLERA; HUMANS; TYPHOID FEVER; VACCINES, ATTENUATED; VACCINES, COMBINED;

EID: 0032783570     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958010-00012     Document Type: Article

References (10)

1. 1. Arya SC. Cholera and typhoid vaccines: a review of current status. Clin Immunother 1996 Jul; 6 (1): 28-38
2. 2. Cryz Jr SJ, Que JU, Levine MM, et al. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults. Infect Immun 1995 Apr; 63 (4): 1336-9
3. 3. Davis R, Spencer CM. Live oral cholera vaccine: a preliminary review of its pharmacology and clinical potential in providing protective immunity against cholera. Clin Immunother 1995 Sep; 4 (3): 235-47
4. 4. Levine MM, Hone D, Tacket C. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as carrier vaccines. Res Microbiol 1990 Sep-Oct; 141; 807-16
5. 5. Viret J-F, Favre D, Wegmüller B, et al. Mucosul and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria. Infect Immun. In press
6. 6. Kollaritsch H, Fürer E, Herzog C, et al. Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines. Infect Immun 1996 Apr; 64: 1454-7
7. 7. Kollaritsch H, Que JU, Kunz C, et al. Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine. J Infect Dis 1997 Apr; 175: 871-5
8. 8. Wasserman SS, Kotloff KL, Losonsky GA, et al. Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect. Am J Epidemiol 1993; 138: 988-93
9. 9. Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull World Health Organ 1994; 72 (6): 957-71
10. 10. Tsai TF, Kollaritsch H, Que JU, et al. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated cholera CVD103-HgR and typhoid Ty21a vaccines [letter]. J Infect Dis 1999 Feb; 179: 522-4